| Literature DB >> 31428743 |
Iltaf Shah1, Bayan Al-Dabbagh1, Alaa Eldin Salem1, Saber A A Hamid1, Neak Muhammad1, Declan P Naughton2.
Abstract
Cannabis products (marijuana, weed, hashish) are among the most widely abused psychoactive drugs in the world, due to their euphorigenic and anxiolytic properties. Recently, hair analysis is of great interest in analytical, clinical, and forensic sciences due to its non-invasiveness, negligible risk of infection and tampering, facile storage, and a wider window of detection. Hair analysis is now widely accepted as evidence in courts around the world. Hair analysis is very feasible to complement saliva, blood tests, and urinalysis. In this review, we have focused on state of the art in hair analysis of cannabis with particular attention to hair sample preparation for cannabis analysis involving pulverization, extraction and screening techniques followed by confirmatory tests (e.g., GC-MS and LC-MS/MS). We have reviewed the literature for the past 10 years' period with special emphasis on cannabis quantification using mass spectrometry. The pros and cons of all the published methods have also been discussed along with the prospective future of cannabis analysis.Entities:
Keywords: Bioanalytical techniques; Cannabis; DART-MS; GC–MS; Hair analysis; Hashish; LC–MS/MS; Marijuana; Psychoactive drugs; THC; Weed
Year: 2019 PMID: 31428743 PMCID: PMC6694587 DOI: 10.1186/s13065-019-0627-2
Source DB: PubMed Journal: BMC Chem ISSN: 2661-801X
Fig. 1Showing the process of extraction and analysis for a THC sample
A comparative analysis of methods for Cannabis determination
| Drugs | Amount of hair | Decontamination | Extraction protocol | Instrument | Linear range | References |
|---|---|---|---|---|---|---|
| THC | 50 | DCM | LLE (MeOH) | UHPLC–MS/MS | 6–27 | [ |
| THC | 50 | DCM | LLE ( | UHPLC–MS/MS | 0.02–5.4 | [ |
| THC | 50 | DCM | Ball mill | LC–MS/MS | 30 | [ |
| THC | 50 | DCM | Digestion(ACN) | LC–MS/MS | 0.2–50 | [ |
| LLE ( | ||||||
| THC, THC-COOH | 20 | MeOH | Ethyl acetate | LC–MS/MS | 1 | [ |
| THC | 20 | Nil | ACN/MeOH/20 mM ammonium formate buffer pH 3(10:10:80, v:v:v) | LC–MS/MS | 2–82 | [ |
| THC-COOH, THC | 50 | Water, acetone | MeOH | LC–MS/MS | 2.5–20 | [ |
| THC-COOH, THC | 50 20 | Petroleum ether | MeOH MeOH | LC-MS/MS LC-TOF | 2.5–20 5–75 | [ [ |
| THC-COOH, THC Cannabinoids | 50 20 | Shampoo, water, acetone | MeOH MeOH | LC-MS/MS LC-TOF | 2.5–20 5–75 | [ [ |
| THC | 20 | Water, acetone | MeOH/ACN/water/2 mM ammonium formate (25:25:50, v/v/v) | LC-TOF | 3–15 | [ |
| THC | 50 | DCM | Enzymatic digestion, LLE (pentane) | GC–MS | 15–20 | [ |
| THC | 10 | Water, acetone | Digestion (1 M NaOH), Derivitisation MSTFA | GC–MS | 10–120 | [ |
| THC | 10–20 | Water, acetone | Digestion with 1 M NaOH Derivatization with BSTFA + 1% TMCS | GC–MS | 15–30 | [ |
| THC | 10 | Petroleum ether | Digestion with 1 M NaOH | GC–MS | 70 | [ |
| THC-THCA-A | 30–50 | Water, acetone, petroleum ether | Digestion with 1 N NaOH LLE with | GC–MS | 20–50 | [ |
| THC | 10 | Petroleum ether, water, ACN | Digestion with 1 M NaOH | GC–MS | 7–31 | [ |
| THC-COOH | 25 | Isopropyl alcohol | LLE with | GC-NCI-MS | 0.02 | [ |
| THC-COOH, THC | 20–50 | Nil | Digestion with 1 M NaOH LLE with | GC-NCI-MS | 0.01 | [ |
| THC-COOH | 20 | DCM | SPE (Bond Elut Certify) Derivatization with TFAA + HFIP | 2D GC–NCI–MS | 0.05 | [ |
| THC | Single hair | DCM | Nil | Nil | Nil | [ |
| THC | 20 | Shampoo, deionized water, acetone | Methanol methanol/water(1:1, v:v) | LC–TOF | 0.0125 | [ |
| THC | 50 | Water, petrol ether, methanol | Methanol, SPE, derivatization MTBSTFA | GC–MS | 0.1-LLOQ | [ |
| THC | 50 | Dichloromethane | Methanol, hexane/ethyl acetate (90:10, v:v) derivatization HFBA/ethyl acetate | GC–MS | Nil | [ |
| THC | Acetone, petroleum ether | Methanol, HS SPE | HPLC–ED | 300 | [ | |
| THC-COOH | 15 | Nil | Methanol, SPE Narc-1 SP cartridge Pentafluoropropanol/PFPA | GC–MS/MS | 0.1 LLOQ | [ |
| THC | 50 | Dichloromethane | Acetonitrile, LLE (hexane:ethyl acetate (55:45, v:v)) SPE: Strata-X cartridge | LC–MS/MS | 0.05 | [ |
| THC | 10 | Nil | Enzyme-linked immunosorbent assays | Immunoassay test | 100 | [ |
| THC-COOH | 30 | Water, acetone, methanol, dichloromethane, phosphate buffer | 0.1 M NaOH, SPE (Waters Milford) | LC/SACI-ESIMS/MS–MS | Nil | [ |
| THC-COOH | 20 | Methanol | NaOH, LLE ( | GC-NCI-MS | 0.025 ng/mg | [ |
| THC,THC-COOH | 20 | Methanol | NaOH, LLE ( | GC-NCI-MS | THC: 2.5 ng/mg THCCOOH: 0.025 ng/mg | [ |
| THC-COOH | Methanol | NaOH, LLE ( | GC-NCI-MS | [ | ||
| THC, THC-COOH | 30–50 | Water, petrol, ether, acetone | NaOH, LLE ( | GC–MS | 0.02 ng/mg | [ |
| THC | 10 | Petroleum ether, deionized water, dichloromethane | NaOH, SPME (PDMS fiber) | GC–MS/MS | 0.031 ng/mg | [ |
| THC | 10 | Petroleum ether, deionized water, dichloromethane | NaOH, HF–LPME | GC–MS/MS | 0.015 ng/mg | [ |
| THC | 10 | Water, acetone | NaOH, NaCl, SFME, deriv. MSTFA | GC–MS | 0.012 ng/mg | [ |
| THC-COOH | 25 | Isopropyl alcohol | NaOH, LLE ( | GC–MS/MS | 0.02 ng/mg | [ |
| THC | 15 | Deionized water, acetone | NaOH, SPME | GC–MS | 0.012 ng/mg | [ |
| THC | 50 | Dichloromethane | NaOH, LLE ( | GC/MS | 0.025 ng/mg | [ |
| THC | 50 | Isopropyl alcohol | NaOH, LLE ( | GC–MS | 0.006 ng/mg | [ |
| THC-COOH | 25 | Isopropyl alcohol | NaOH, LLE ( | GC–MS/MS | 0.015 ng/mg | [ |
| THC | 10 | Deionised water, petroleum ether, dichloromethane | NaOH, SPME, MSTFA | GC–MS | 0.05 ng/mg | [ |
| THC | Deionised water, petroleum ether, dichloromethane | NaOH, HS-SPDE, MSTFA | GC–MS | 0.14 ng/mg | [ | |
| THC | Dichlorometane | NaOH | GC–MS | 0.1 ng/mg | [ | |
| THC-COOH | 20 | Dichlorometane | NaOH, SPE( | GC–MS | 0.3 | [ |
| THC-COOH | Nil | NaOH, hexane/ethyl acetate | GC–MS | 0.3 | [ | |
| THC, THC-COOH | KH2PO4 1 M, water, methanol | Hexane/ethyl acetate, TMSI/HFIP/PFPA | GC–MS/MS | 0.1–1 | [ | |
| THC-COOH | 50 | Nil | NaOH, LLE ( | GC–MS/MS | Nil | [ |
| THC-COOH | 20 | Dichloromethane | NaOH, SPE ( | GC–MS/MS | 0.05 LLOQ | [ |
| THC-COOH | 20 | Methanol | NaOH, LLE ( | GC–MS | 0.025 ng/mg | [ |
| THC-COOH | 20 | Dichloromethane | NaOH, SPE ( | GC–MS | Nil | [ |
| THC-COOH | 50 | Dichloromethane | NaOH, LLE (n-heptane-ethyl acetate 9:1 v:v) PFPOH/PFPA | GC–MS/MS | 0.05 ng/mg | [ |
| THC | 50 | DCM | MeOH | UHPLC–ESI–MS/MS (QqQ) | 6–27 | [ |
| THC | 50 | DCM | LLE with | LC–ESI–MS/MS (QqQ) | 0.2–50 | [ |
| THC, THC-COOH | 20 | Washing sonication MeOH | LLE ethyl acetate | LC–ESI–MS/MS (QqQ) | 1 | [ |
| THC, THC-COOH | 50 | Water acetone petroleum ether | MeoH | LC–ESI–MS/MS (QTrap) | LOQ 2.5–20 | [ |
| THC | 50 | DCM | LLE pentane | GC-EI/MS | 15–20 | [ |
| THC | 15–30 | Water acetone | HS-SPME | GC-EI/MS | 10–20 | [ |
| THC | 10 | Petroleum ether | HS-SPME | GC-EI/MS | 70 | [ |
| THC | 10 | DCM water petroleum ether | HS-SPME | GC-EI/MS/MS (IT) | 7–31 | [ |
| THC-COOH | 25 | Isopropyl alcohol | LLE | GC–NCI–MS/MS (QqQ) | 0.02 | [ |
| THC THC-COOH | 20-50 | NaoH | LLE | GC–NCI–MS/MS (QqQ) | 0.01 | [ |
| Δ-9-tetrahydrocannabinol | DMC | LLE | DART-MS LC/MS/MS | Nil | [ | |
| THCA-A, THC | Water acetone, petroleum ether | methanol | LC–MS/MS MRM mode | 2.5 pg/mg 20 pg/mg for THC | [ | |
| THCA-A, THC | Water acetone , petroleum ether | alkaline hydrolysis, followed by LLE | GC–MS monitoring (SIM) mode analysis | LOD (THCA A) 0.05 ng/mg LOD (THC) 0.02 ng/mg | [ | |
| THCA-A and THC | Water acetone, petroleum ether | 2 mL MeOH | (LC–MS/MS) | n 1–2.5 pg/mg THCA-A 5–10 pg/mg for THC | [ | |
THC-COOH THC THCA-A | 1–2 mm | Water acetone | MeOH | LC–MS/MS GC–MS HS–SPME–GC–MS | 1.6–36 0.71–3.27 0–2.75 | [ |
| THCCOOH THC THC-OH | 10 mg | Chloroform/isopropanol | MeOH solid phase extraction | GC–MS/MS | 0.05 ng/mL, 0.004 ng/mL | [ |
| THC-COOHTHC and THC | 200-mg | Methanol in an ultrasonic bath | LLE ethyl acetate NaOH vertex | LC–MS/MS s | 0.1 ng/mL | [ |
| THC-COOH | 25 mg | Methyl alcohol | Amiodarone VMA-T M3 reagent | UHPLC–MS/MS | 0.09 pg/mg | [ |
| Δ-9-THC, cannabidiol cannabinol | 25 mg | Methyl alcohol Diethyl ether | VMA-T M3 reagent | UHPLC–MS/MS | 0.01 to 0.1 ng | [ |
| THC | 60 mg | Methanol SDS wash | LLE | UPLC SEM | 0.02 | [ |
| THC CBN CBD | 0.5 g | Mechanical stirring DMC Ultrapure water | LLE HPLC | HPLC LC/MS/MS | Nil | [ |
| THCCOOH | 20 mg) | Methanol | 1 M NaOH acetic acid | LC/MS/MS | LOQ (2 pg/20 mg hair) | [ |
| THC, CBN, CBD | 2.0 M sodium hydroxide | Liquid–liquid extraction with hexane/ethyl acetate | HPLC–MS/MS | 0.25, 0.21, and 0.22 ng g | [ | |
| Synthetic cannabinoids | 100 mg | 0.5 M sodium hydroxide | Liquid–liquid extraction with hexane/ethyl acetate | 1260 HPLC-Q-TOF | 10 | [ |
| THCCOOH THC | 20 mg | 1 M sodium hydroxide | Liquid–liquid extraction with hexane/ethyl acetate | GC/MS/MS-NCI | Nil | [ |
| THC, CBD, CBN | 50–100 mg | Water, petrol ether, methanol | SPE | GC–MS | 0.1 pg/mg | [ |
| THC, CBD, CBN | 20 mg | Shampoo, deionized water, acetone, air-dried overnight | 1 mL methanol/water (1:1 v1:v1) filtered 0.45 PTFE syringe filter | LC–TOFMS | Nil | [ |
| THC, CBD, CBN | 50 mg | Dichloromethane | LLE | GC–MS | Nil | [ |
| THC, CBD, CBN | Acetone, petrol ether | Ultra sonication | HPLC–ED | 300 (ng/mg) | [ | |
| THC and THC-COOH | 20 mg | Washed in methanol for 30 s | Acidified methanol (2 mL) for 18 h at 45 °C | LC–MS/MS | LoQ of 75 pg/mg | [ |
| 11-Nor-9-carboxy-THC | Methanol/water wash follow NaOH digest at 75 °C | Hexane/ethyl acetate liquid extraction | HPLC SCIEX 6500 + QTRAP system | 0.2 pg/mg | [ | |
| THC], THC-OH, THC-COOH | segmented in 1 cm | Methanol chloroform/isopropanol | Ultra sonication SPE | GC–MS/MS | 0.05 ng/mL | [ |
| THC, CBD, CBN | Sodium hydroxide solution | Liquid–liquid extraction (LLE) | GC–MS/MS | 0.01 ng/mg | [ | |
| THC | 20 mg | methanol | Acidified methanol 18 h at 45 C | LC–MS/MS. | 75 pg/mg | [ |
| THC, CBN | Water, acetone, NaOH | Solid-phase extraction | GC–MS/MS | [ | ||
| THC-COOH | 10 mg | 0.1% sodium dodecyl sulfate, water, and methanol | Micro pulverized extraction (MPE) | (LC/MS/MS | 0.2 pg/mg | [ |
| Cannabis | 30 mg | Tween 80, Acetone | Methanolic incubation Sonication | LC-HRMS | 2 to 30 pg/mg | [ |
| Cannabis | Methanol | 6-h ultrasonic-assisted methanolic extraction | GC–MS/MS | [ | ||
| Synthetic cannabinoids | Samples were fortified by soaking | Pressurized liquid extraction (PLE) SPE | HPLC-HRMS | 9 to 40 pg/mg | [ | |
THC CBN CBD | 3 − 6 cm 100 mg | LLE | GC–MS SIM | 0.01 0.06 0.03 | [ | |
| D9-THC | 50 mg | 0.1 N HCl NaOH 2 M | Liquid–liquid extraction | GC–MS ELISA | [ | |
| THC, CBN, CBD | 5 cm | Water methanol | MALDI-MS/MS | Quadrupole LC–MS/MS | [ |
Fig. 2MRM chromatograms relative to a hair positive sample from a cannabis user, showing the MRM transitions applied. a, b THC-D3, c, d CBD, e, f THC, g, h CBN, i–l 11-OH-THC
(reproduced with permission from Elsevier, Ref. [118])
Fig. 3Representative chromatograms of THC-COOH and THC-COOH-d3 in an authentic hair sample of MRM (a), and MS3 (b) modes
(reproduced with permission from Elsevier, Ref. [122])
Fig. 4TIC and EIC of m/z 315.2319 from a DART hair scan (scan rate = 0.2 mm/s) of a cannabis user hair sample
(reproduced with permission from John Wiley and Sons, reference, [88])